MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

α-synuclein and deficits of membrane trafficking in Parkinson’s Disease

A. Sarchione, A. Marchand, F. Filippini, T. Galli, JM. Taymans, MC. Chartier-Harlin (Lille, France)

Meeting: MDS Virtual Congress 2021

Abstract Number: 799

Keywords: Alpha-synuclein, Heat shock proteins(HSP), Parkinson’s

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: Aim of the study is to understand the physical and functional relationships between the PD-associated protein α-synuclein and some of the Soluble N-ethylmaleimide-sensitive-factor Attachment proteins Receptor, regulators of vesicular and membrane fusion events.

Background: Parkinson’s Disease (PD) is a neurodegenerative disorder characterized by defects in membrane trafficking. SNCA, encoding α-synuclein (α-syn), is a major genetic determinants of PD pathogenesis involved in membrane trafficking. α-syn has recently emerged as regulator of SNARE (Soluble N-ethylmaleimide-sensitive-factor Attachment protein Receptor)-dependent vesicle fusion. Recently the vesicular SNARE protein VAMP4 emerged as novel PD-risk factor and VAMP7 as a mediator of ER-phagy secretion. Here we proposed to investigate the potential functional interactions between α-syn and VAMPs 4 and 7 as well as the effect of VAMPs on α-syn release in extracellular space.

Method: The co-localization between α-syn and VAMPs was analyzed by immunocytochemistry and Proximity Ligation Assay. The released α-syn exocytosis was measured at different time points upon α-syn over-expression. Extracellular vesicles were isolated from cell culture media in VAMPs (2, 4, 7) KO cellular model stably overexpressing α-syn. Pharmacological treatment with MG132 was performed in the VAMPs KO cells in order to analyze the effect of proteasome inhibition on α-syn exocytosis VAMPs-dependent.

Results: We present results of PLA and co-localization showing a potential interaction between α-syn and VAMPs 2 and 7. Inhibition of proteasome activity induces an increase of intracellular α-syn protein levels as well as an increased α-syn release into extracellular vesicles after 24h. We observed a reduced α-syn release in exosomes isolated from PC12 KO for VAMP4 and VAMP7 compared to WT PC12 cells.

Conclusion: α-syn and VAMPs are both involved in vesicular and membrane trafficking and our results suggest an involvement of VAMPs in vesicles release and α-syn exocytosis. In our perspectives, we will evaluate the effect of VAMPs on the α-syn aggregation and exocytosis in order to evaluate if the α-syn homeostasis could be modulated by SNARE proteins.

To cite this abstract in AMA style:

A. Sarchione, A. Marchand, F. Filippini, T. Galli, JM. Taymans, MC. Chartier-Harlin. α-synuclein and deficits of membrane trafficking in Parkinson’s Disease [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/%ce%b1-synuclein-and-deficits-of-membrane-trafficking-in-parkinsons-disease/. Accessed May 22, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/%ce%b1-synuclein-and-deficits-of-membrane-trafficking-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley